RE: The Daily Telegraph Today9 May 2020 13:04
Telegraph final part 3
Right now, investors are backing businesses in the race for Covid-19 treatments. Any company that gets a vaccine or a drug into Phase II or III trials is already witnessing a sharp spike in its share price. And, of course, any breakthrough in treating the virus is going to be massive. In truth, however, investors should be looking at pharmaceuticals and life sciences more widely. For the last decade, it has been outshone by the internet and the app economy. But this crisis will usher in a new global age – and one that will allow all its major companies to renew themselves and start growing again.